deferoxamine has been researched along with Endomyocardial Fibrosis in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Endomyocardial Fibrosis: A condition characterized by the thickening of the ventricular ENDOCARDIUM and subendocardium (MYOCARDIUM), seen mostly in children and young adults in the TROPICAL CLIMATE. The fibrous tissue extends from the apex toward and often involves the HEART VALVES causing restrictive blood flow into the respective ventricles (CARDIOMYOPATHY, RESTRICTIVE).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Y | 2 |
| Wang, H | 1 |
| Cui, L | 1 |
| Liu, Y | 1 |
| Chu, X | 1 |
| Liu, Z | 1 |
| Zhang, J | 1 |
| Chu, L | 1 |
| Hamdy, NA | 1 |
| Andrew, SM | 1 |
| Shortland, JR | 1 |
| Boletis, J | 1 |
| Raftery, AT | 1 |
| Kanis, JA | 1 |
| Brown, CB | 1 |
2 other studies available for deferoxamine and Endomyocardial Fibrosis
| Article | Year |
|---|---|
Continuing treatment with Salvia miltiorrhiza injection attenuates myocardial fibrosis in chronic iron-overloaded mice.
Topics: Animals; Collagen Type I; Collagen Type III; Deferoxamine; Drugs, Chinese Herbal; Endomyocardial Fib | 2015 |
Fatal cardiac zygomycosis in a renal transplant patient treated with desferrioxamine.
Topics: Adult; Deferoxamine; Endomyocardial Fibrosis; Heart Ventricles; Humans; Immunosuppressive Agents; Ki | 1989 |